145 related articles for article (PubMed ID: 26464974)
1. Disruption of Src Is Associated with Phenotypes Related to Williams-Beuren Syndrome and Altered Cellular Localization of TFII-I.
Sinai L; Ivakine EA; Lam E; Deurloo M; Dida J; Zirngibl RA; Jung C; Aubin JE; Feng ZP; Yeomans J; McInnes RR; Osborne LR; Roder JC
eNeuro; 2015; 2(2):. PubMed ID: 26464974
[TBL] [Abstract][Full Text] [Related]
2. Transcription Factor 2I Regulates Neuronal Development via TRPC3 in 7q11.23 Disorder Models.
Deurloo MHS; Turlova E; Chen WL; Lin YW; Tam E; Tassew NG; Wu M; Huang YC; Crawley JN; Monnier PP; Groffen AJA; Sun HS; Osborne LR; Feng ZP
Mol Neurobiol; 2019 May; 56(5):3313-3325. PubMed ID: 30120731
[TBL] [Abstract][Full Text] [Related]
3. Essential role of the N-terminal region of TFII-I in viability and behavior.
Lucena J; Pezzi S; Aso E; Valero MC; Carreiro C; Dubus P; Sampaio A; Segura M; Barthelemy I; Zindel MY; Sousa N; Barbero JL; Maldonado R; Pérez-Jurado LA; Campuzano V
BMC Med Genet; 2010 Apr; 11():61. PubMed ID: 20403157
[TBL] [Abstract][Full Text] [Related]
4. Consistent hypersocial behavior in mice carrying a deletion of
Martin LA; Iceberg E; Allaf G
Brain Behav; 2018 Jan; 8(1):e00895. PubMed ID: 29568691
[TBL] [Abstract][Full Text] [Related]
5. Williams-Beuren syndrome hypercalcemia: is TRPC3 a novel mediator in calcium homeostasis?
Letavernier E; Rodenas A; Guerrot D; Haymann JP
Pediatrics; 2012 Jun; 129(6):e1626-30. PubMed ID: 22566418
[TBL] [Abstract][Full Text] [Related]
6. Intracisternal Gtf2i Gene Therapy Ameliorates Deficits in Cognition and Synaptic Plasticity of a Mouse Model of Williams-Beuren Syndrome.
Borralleras C; Sahun I; Pérez-Jurado LA; Campuzano V
Mol Ther; 2015 Nov; 23(11):1691-1699. PubMed ID: 26216516
[TBL] [Abstract][Full Text] [Related]
7. TFII-I regulates target genes in the PI-3K and TGF-β signaling pathways through a novel DNA binding motif.
Segura-Puimedon M; Borralleras C; Pérez-Jurado LA; Campuzano V
Gene; 2013 Sep; 527(2):529-36. PubMed ID: 23831514
[TBL] [Abstract][Full Text] [Related]
8. TFII-I/Gtf2i and Erythro-Megakaryopoiesis.
Gurumurthy A; Wu Q; Nar R; Paulsen K; Trumbull A; Fishman RC; Brand M; Strouboulis J; Qian Z; Bungert J
Front Physiol; 2020; 11():590180. PubMed ID: 33101065
[TBL] [Abstract][Full Text] [Related]
9. Essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.
Enkhmandakh B; Makeyev AV; Erdenechimeg L; Ruddle FH; Chimge NO; Tussie-Luna MI; Roy AL; Bayarsaihan D
Proc Natl Acad Sci U S A; 2009 Jan; 106(1):181-6. PubMed ID: 19109438
[TBL] [Abstract][Full Text] [Related]
10. The contribution of GTF2I haploinsufficiency to Williams syndrome.
Chailangkarn T; Noree C; Muotri AR
Mol Cell Probes; 2018 Aug; 40():45-51. PubMed ID: 29305905
[TBL] [Abstract][Full Text] [Related]
11. Action of TFII-I outside the nucleus as an inhibitor of agonist-induced calcium entry.
Caraveo G; van Rossum DB; Patterson RL; Snyder SH; Desiderio S
Science; 2006 Oct; 314(5796):122-5. PubMed ID: 17023658
[TBL] [Abstract][Full Text] [Related]
12. A mouse single-copy gene, Gtf2i, the homolog of human GTF2I, that is duplicated in the Williams-Beuren syndrome deletion region.
Wang YK; Pérez-Jurado LA; Francke U
Genomics; 1998 Mar; 48(2):163-70. PubMed ID: 9521869
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of Williams-Beuren syndrome: TFII-I regulated targets involved in craniofacial development.
Makeyev AV; Bayarsaihan D
Cleft Palate Craniofac J; 2011 Jan; 48(1):109-16. PubMed ID: 20500075
[TBL] [Abstract][Full Text] [Related]
14. RNA-Seq analysis of Gtf2ird1 knockout epidermal tissue provides potential insights into molecular mechanisms underpinning Williams-Beuren syndrome.
Corley SM; Canales CP; Carmona-Mora P; Mendoza-Reinosa V; Beverdam A; Hardeman EC; Wilkins MR; Palmer SJ
BMC Genomics; 2016 Jun; 17():450. PubMed ID: 27295951
[TBL] [Abstract][Full Text] [Related]
15. Expression of the transcription factor, TFII-I, during post-implantation mouse embryonic development.
Fijalkowska I; Sharma D; Bult CJ; Danoff SK
BMC Res Notes; 2010 Jul; 3():203. PubMed ID: 20642858
[TBL] [Abstract][Full Text] [Related]
16. Structural variants in genes associated with human Williams-Beuren syndrome underlie stereotypical hypersociability in domestic dogs.
vonHoldt BM; Shuldiner E; Koch IJ; Kartzinel RY; Hogan A; Brubaker L; Wanser S; Stahler D; Wynne CDL; Ostrander EA; Sinsheimer JS; Udell MAR
Sci Adv; 2017 Jul; 3(7):e1700398. PubMed ID: 28776031
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterisation of GTF2IRD2, a novel fusion gene and member of the TFII-I family of transcription factors, deleted in Williams-Beuren syndrome.
Tipney HJ; Hinsley TA; Brass A; Metcalfe K; Donnai D; Tassabehji M
Eur J Hum Genet; 2004 Jul; 12(7):551-60. PubMed ID: 15100712
[TBL] [Abstract][Full Text] [Related]
18. Identification of GTF2IRD1, a putative transcription factor within the Williams-Beuren syndrome deletion at 7q11.23.
Franke Y; Peoples RJ; Francke U
Cytogenet Cell Genet; 1999; 86(3-4):296-304. PubMed ID: 10575229
[TBL] [Abstract][Full Text] [Related]
19. Mutation of Gtf2ird1 from the Williams-Beuren syndrome critical region results in facial dysplasia, motor dysfunction, and altered vocalisations.
Howard ML; Palmer SJ; Taylor KM; Arthurson GJ; Spitzer MW; Du X; Pang TY; Renoir T; Hardeman EC; Hannan AJ
Neurobiol Dis; 2012 Mar; 45(3):913-22. PubMed ID: 22198572
[TBL] [Abstract][Full Text] [Related]
20. Reduced fear and aggression and altered serotonin metabolism in Gtf2ird1-targeted mice.
Young EJ; Lipina T; Tam E; Mandel A; Clapcote SJ; Bechard AR; Chambers J; Mount HT; Fletcher PJ; Roder JC; Osborne LR
Genes Brain Behav; 2008 Mar; 7(2):224-34. PubMed ID: 17680805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]